Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Will Exercise Enforcement Discretion On Pedigrees

This article was originally published in The Pink Sheet Daily

Executive Summary

The agency will require pedigrees to trace transactions back to the authorized distributor of record while a preliminary injunction is in effect.

You may also be interested in...



GSK Warns Pharmacists Of Ziagen, Combivir Mix Up

FDA issues a MedWatch alert April 10 advising of misbranded bottles of the HIV drug Combivir containing Ziagen instead.

GSK Warns Pharmacists Of Ziagen, Combivir Mix Up

FDA issues a MedWatch alert April 10 advising of misbranded bottles of the HIV drug Combivir containing Ziagen instead.

Drug Pedigree Rule In Doubt

Federal court issues preliminary injunction barring FDA from enforcing the PDMA pedigree final rule.

Topics

UsernamePublicRestriction

Register

PS017586

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel